Disc Medicine, Inc.
IRON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001816736
In the last 90 days, Disc Medicine, Inc. insiders filed 0 open-market purchases and 9 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $3.13B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Disc Medicine, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 121
- −8 vs. Q1 2024
- Shares held
- 27.6M
- +5.32M (+23.9%) vs. Q1 2024
- Total value
- $1.24B
- −$139.7M (−10.1%) vs. Q1 2024
- New holders
- 29
- 55 more added
- Sold out
- 37
- 30 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 216 | $3.13B |
| Q1 2026 | 203 | $2.67B |
| Q4 2025 | 197 | $3.04B |
| Q3 2025 | 168 | $2.26B |
| Q2 2025 | 152 | $1.80B |
| Q1 2025 | 157 | $1.65B |
| Q4 2024 | 152 | $1.68B |
| Q3 2024 | 132 | $1.35B |
| Q2 2024 | 121 | $1.24B |
| Q1 2024 | 130 | $1.38B |
| Q4 2023 | 112 | $1.17B |
| Q3 2023 | 91 | $934.0M |
| Q2 2023 | 90 | $848.7M |
| Q1 2023 | 45 | $309.6M |
| Q4 2022 | 35 | $215.8M |
| Q3 2022 | 44 | $43.9M |
| Q2 2022 | 51 | $43.8M |
| Q1 2022 | 57 | $39.6M |
| Q4 2021 | 62 | $93.8M |
| Q3 2021 | 62 | $103.5M |
| Q2 2021 | 55 | $165.3M |
| Q1 2021 | 49 | $346.6M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Disc Medicine, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 321,521 | $14.5M | 0.01% | −4,203−1.3% | Reduced |
| Geode Capital Management, LLC | 403,736 | $18.2M | 0.00% | +157,962+64.3% | Added |
| FMR LLC | 413,097 | $18.6M | 0.00% | +9,565+2.4% | Added |
| Janus Henderson Group PLC | 445,873 | $20.1M | 0.01% | −75,900−14.5% | Reduced |
| TCG Crossover Management, LLC | 486,957 | $21.9M | 2.29% | +486,957 | New |
| Saturn V Capital Management LLC | 503,089 | $22.7M | 8.57% | +248,286+97.4% | Added |
| Perceptive Advisors LLC | 553,437 | $24.9M | 0.60% | −386,429−41.1% | Reduced |
| State Street Corp | 592,795 | $26.7M | 0.00% | −498,416−45.7% | Reduced |
| Adage Capital Partners GP, L.L.C. | 618,501 | $27.9M | 0.05% | +44,037+7.7% | Added |
| Point72 Asset Management, L.P. | 761,429 | $34.3M | 0.11% | +761,429 | New |
| Logos Global Management LP | 925,000 | $41.7M | 4.80% | +925,000 | New |
| Deerfield Management Company, L.P. (Series C) | 1,023,265 | $46.1M | 0.77% | +357,730+53.8% | Added |
| Vanguard Group Inc | 1,111,424 | $50.1M | 0.00% | +328,673+42.0% | Added |
| Price T Rowe Associates Inc | 1,122,194 | $50.6M | 0.01% | +177,981+18.8% | Added |
| BlackRock Inc. | 1,437,542 | $64.8M | 0.00% | +535,947+59.4% | Added |
| Frazier Life Sciences Management, L.P. | 1,754,834 | $79.1M | 3.70% | +969,834+123.5% | Added |
| Wellington Management Group LLP | 1,756,495 | $79.2M | 0.01% | +1,086,013+162.0% | Added |
| OrbiMed Advisors LLC | 1,785,571 | $80.5M | 1.72% | +83,334+4.9% | Added |
| Bain Capital Life Sciences Investors, LLC | 1,795,735 | $80.9M | 8.89% | +478,522+36.3% | Added |
| Atlas Venture Life Science Advisors, LLC | 2,509,456 | $113.1M | 11.91% | +222,223+9.7% | Added |
| Paradigm Biocapital Advisors LP | 2,704,718 | $121.9M | 4.67% | +314,816+13.2% | Added |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −363,468−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −193,240−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −119,312−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −107,593−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −102,016−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −76,800−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −74,777−100.0% | Sold out |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −61,500−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −60,129−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −43,806−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −25,372−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −19,698−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −17,952−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −14,711−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −13,488−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −11,400−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −8,520−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −7,872−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −6,759−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −6,453−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −4,861−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −4,649−100.0% | Sold out |
| Bleakley Financial Group, LLC | 0 | $0 | 0.00% | −4,572−100.0% | Sold out |
| Simplicity Wealth,LLC | 0 | $0 | 0.00% | −4,566−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −4,560−100.0% | Sold out |
| Fiduciary Trust Co | 0 | $0 | 0.00% | −4,051−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −3,385−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −3,317−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −896−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −529−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −356−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −388−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −67−100.0% | Sold out |
| Private Wealth Management Group, LLC | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |